Introduction of in vitro contracture test, genetic and bioptical eyamination for the diagnosis of sesceptibility to malignant hyperthermia
Project goals
Introduction of in vitro contracture test for diagnosis of malignant hyperthermia along with genetic examination of the pacient and his family and subsequent bioptical examination of the muscle biopsy.
Keywords
MalignanthyperthermiaIVCTMusclebiopsyGeneticsRYR 1Aneathesiad base
Public support
Provider
Ministry of Health
Programme
Research and development in the sphere or surgery
Call for proposals
Výzkum a vývoj v oblasti Kardiovaskulárních chorob 12 (SMZ0ND2001)
Main participants
Fakultní nemocnice Brno
Contest type
VS - Public tender
Contract ID
—
Alternative language
Project name in Czech
Zavedení in vitro kontrakčního testu, genetického a bioptického vyšetření k diagnostice maligní hypertermie
Annotation in Czech
Zavedení in vitro kontrakčního testu spolu s genetickým vyšetřením pacienta a jeho rodiny k diagnostice maligní hypertermie.
Scientific branches
R&D category
—
CEP classification - main branch
EB - Genetics and molecular biology
CEP - secondary branch
FB - Endocrinology, diabetology, metabolism, nutrition
CEP - another secondary branch
FJ - Surgery including transplantology
10603 - Genetics and heredity (medical genetics to be 3)
10604 - Reproductive biology (medical aspects to be 3)
10605 - Developmental biology
10608 - Biochemistry and molecular biology
10609 - Biochemical research methods
30101 - Human genetics
30202 - Endocrinology and metabolism (including diabetes, hormones)
30212 - Surgery
30213 - Transplantation
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
Byly zavedeny metody vytypovat jedince s dispozicí pro rozvoj maligní hypertenze.
Solution timeline
Realization period - beginning
Jan 1, 2001
Realization period - end
Jan 1, 2003
Project status
U - Finished project
Latest support payment
—
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP/2004/MZ0/MZ04ND/U/N/3:1
Data delivery date
Jul 12, 2004
Finance
Total approved costs
1,920 thou. CZK
Public financial support
1,900 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
11 thou. CZK
Basic information
Recognised costs
1 920 CZK thou.
Public support
1 900 CZK thou.
98%
Provider
Ministry of Health
CEP
EB - Genetics and molecular biology
Solution period
01. 01. 2001 - 01. 01. 2003